Mergers & Acquisitions - Stallergenes

Filter

Current filters:

Stallergenes

Popular Filters

82 to 106 of 847 results

Biotoscana to buy United Medical to create regional specialty pharma group in South America

14-01-2014

Colombia-based Grupo Biotoscana has signed an agreement to acquire Brazilian drugmaker United Medical…

Grupo BiotoscanaMergers & AcquisitionsPharmaceuticalSouth AmericaUnited Medical

Agenus to acquire Switzerland’s 4-Antibody AG

14-01-2014

US biotech firm Agenus has entered into a definitive agreement to acquire 4-Antibody AG, a private Switzerland-headquartered…

4-Antibody AGAgenusBiotechnologyGITRMergers & AcquisitionsOncologyOX40

McKesson acquisition of German rival Celesio fails

14-01-2014

USA-based health care service and information technology giant McKesson Corp revealed yesterday that…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

Galena Biopharma acquires Mills Pharmaceuticals

14-01-2014

US drugmaker Galena Biopharma revealed that it has acquired Mills Pharmaceuticals, which has the worldwide…

AnagrelideGalena BioPharmaHematologyMergers & AcquisitionsMills PharmaceuticalsPharmaceutical

Big pharma's need to tap M&A for growth will persist in 2014, while dealmaking landscape becomes more competitive, says EY

13-01-2014

Big pharma stayed on the sidelines in the 2013 mergers and acquisitions market despite a continuing need…

GlobalMergers & AcquisitionsPharmaceutical

Regeneron amends investor agreement with Sanofi

Regeneron amends investor agreement with Sanofi

13-01-2014

US biotech firm Regeneron Pharmaceuticals says it has amended and restated its investor agreement with…

BiotechnologyMergers & AcquisitionsRegeneronSanofi

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Alnylam to acquire Merck’s Sirna Therapeutics

Alnylam to acquire Merck’s Sirna Therapeutics

13-01-2014

US RNAi therapeutics specialist Alnylam Pharmaceuticals says it has reached agreement to acquire US pharma…

Alnylam PharmaceuticalsBiotechnologyMerck & CoMergers & AcquisitionsSirna Therapeutics

Akorn gains rights to Betimol from Santen

10-01-2014

US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Endo divests remainder of HealthTronics for up to $130 million

09-01-2014

Endo Health Solutions says it has entered into a definitive agreement to sell its HealthTronics business…

Endo Health SolutionshealthTronicsMergers & AcquisitionsPharmaceutical

NuPathe receives counter offer from Teva topping Endo bid

09-01-2014

US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

Forest Labs to spend $2.9 billion on acquiring Aptalis

Forest Labs to spend $2.9 billion on acquiring Aptalis

09-01-2014

Confirming recent speculative reports, US drugmaker Forest Laboratories says it has entered into a definitive…

AptalisForest LaboratoriesGastro-intestinalsMergers & AcquisitionsPharmaceuticalRare diseases

Eddingpharm acquires global rights to oncology assets, including telatinib, from ACT Biotech

08-01-2014

Chinese drug firm Eddingpharm has entered into an asset purchase agreement (APA) with a private, venture…

ACT BiotechEddingpharmMergers & AcquisitionsOncologyPharmaceuticaltelatinib

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

Probiodrug sells its CDK9 inhibitor program to AstraZeneca

06-01-2014

Privately-held German company Probiodrug says it has transferred its experimental cyclin-dependent kinase…

AstraZenecaInflammatory diseasesMergers & AcquisitionsOncologyPharmaceuticalProbiodrug

Ikaria sells commercial business to Madison Dearborn for $1.6 billion

03-01-2014

US critical care company Ikaria says that its investor group and employee shareholders have reached a…

IkariaInomaxMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Senesco enters merger accord with Fabrus

31-12-2013

USA-based biotech firm Senesco Technologies has agreed to terms and executed a non-binding Letter of…

BiotechnologyFabrusMergers & AcquisitionsOncologySenesco Technologies

Hepalink to acquire USA’s Scientific Protein Laboratories

27-12-2013

China’s Shenzhen Hepalink Pharmaceutical has entered into a stock purchase agreement to acquire USA-based…

GenericsheparinMergers & AcquisitionsScientific Protein LaboratoriesShenzhen Hepalink Pharmaceutical

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva

27-12-2013

Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

Two Latin America acquisitions for Gedeon Richter

23-12-2013

In what was a busy couple of days for Hungary’s largest drugmaker Gedeon Richter, the company announced…

BrazilGedeon RichterMergers & AcquisitionsNext PharmaPharmaceuticalSouth AmericaWomen's Health

82 to 106 of 847 results

Company Spotlight

Fibrotech

Fibrotech

Back to top